BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31205679)

  • 1. Cytoplasmic translocation of nuclear LSD1 (
    Yabuta S; Shidoji Y
    Hepat Oncol; 2019 Jun; 6(2):HEP13. PubMed ID: 31205679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lysine-specific demethylase 1 by the acyclic diterpenoid geranylgeranoic acid and its derivatives.
    Sakane C; Okitsu T; Wada A; Sagami H; Shidoji Y
    Biochem Biophys Res Commun; 2014 Jan; 444(1):24-9. PubMed ID: 24406160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of lysine-specific demethylase-1 activity in the nuclear extracts by flow-injection based time-of-flight mass spectrometry.
    Sakane C; Ohta H; Shidoji Y
    J Clin Biochem Nutr; 2015 Mar; 56(2):123-31. PubMed ID: 25759518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel potent inhibitors of the histone demethylase KDM1A (LSD1), orally active in a murine promyelocitic leukemia model.
    Trifirò P; Cappa A; Brambillasca S; Botrugno OA; Cera MR; Zuffo RD; Dessanti P; Meroni G; Thaler F; Villa M; Minucci S; Mercurio C; Varasi M; Vianello P
    Future Med Chem; 2017 Jul; 9(11):1161-1174. PubMed ID: 28722470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A).
    Li Z; Ding L; Li Z; Wang Z; Suo F; Shen D; Zhao T; Sun X; Wang J; Liu Y; Ma L; Zhao B; Geng P; Yu B; Zheng Y; Liu H
    Acta Pharm Sin B; 2019 Jul; 9(4):794-808. PubMed ID: 31384539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of nuclear translocation of mutant cytoplasmic p53 by geranylgeranoic acid in a human hepatoma cell line.
    Iwao C; Shidoji Y
    Sci Rep; 2014 Mar; 4():4419. PubMed ID: 24658405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship.
    Vianello P; Sartori L; Amigoni F; Cappa A; Fagá G; Fattori R; Legnaghi E; Ciossani G; Mattevi A; Meroni G; Moretti L; Cecatiello V; Pasqualato S; Romussi A; Thaler F; Trifiró P; Villa M; Botrugno OA; Dessanti P; Minucci S; Vultaggio S; Zagarrí E; Varasi M; Mercurio C
    J Med Chem; 2017 Mar; 60(5):1693-1715. PubMed ID: 28186757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A).
    Borrello MT; Schinor B; Bartels K; Benelkebir H; Pereira S; Al-Jamal WT; Douglas L; Duriez PJ; Packham G; Haufe G; Ganesan A
    Bioorg Med Chem Lett; 2017 May; 27(10):2099-2101. PubMed ID: 28390942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4-mediated pyroptosis in human hepatoma-derived HuH-7 cells induced by a branched-chain polyunsaturated fatty acid, geranylgeranoic acid.
    Yabuta S; Shidoji Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32270855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.
    Dai XJ; Liu Y; Xiong XP; Xue LP; Zheng YC; Liu HM
    J Med Chem; 2020 Dec; 63(23):14197-14215. PubMed ID: 32931269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid downregulation of cyclin D1 induced by geranylgeranoic acid in human hepatoma cells.
    Shimonishi S; Muraguchi T; Mitake M; Sakane C; Okamoto K; Shidoji Y
    Nutr Cancer; 2012 Apr; 64(3):473-80. PubMed ID: 22369110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A.
    Pieroni M; Annunziato G; Azzali E; Dessanti P; Mercurio C; Meroni G; Trifiró P; Vianello P; Villa M; Beato C; Varasi M; Costantino G
    Eur J Med Chem; 2015 Mar; 92():377-86. PubMed ID: 25585008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis.
    Shidoji Y; Iwao C
    Biochem Biophys Rep; 2021 Dec; 28():101176. PubMed ID: 34869922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.
    Nagasaka M; Tsuzuki K; Ozeki Y; Tokugawa M; Ohoka N; Inoue Y; Hayashi H
    Biol Pharm Bull; 2019; 42(3):481-488. PubMed ID: 30828079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A.
    Vianello P; Botrugno OA; Cappa A; Ciossani G; Dessanti P; Mai A; Mattevi A; Meroni G; Minucci S; Thaler F; Tortorici M; Trifiró P; Valente S; Villa M; Varasi M; Mercurio C
    Eur J Med Chem; 2014 Oct; 86():352-63. PubMed ID: 25173853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine-Specific Demethylase 1A (KDM1A/LSD1): Product Recognition and Kinetic Analysis of Full-Length Histones.
    Burg JM; Gonzalez JJ; Maksimchuk KR; McCafferty DG
    Biochemistry; 2016 Mar; 55(11):1652-62. PubMed ID: 26673564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.
    Schulz-Fincke J; Hau M; Barth J; Robaa D; Willmann D; Kürner A; Haas J; Greve G; Haydn T; Fulda S; Lübbert M; Lüdeke S; Berg T; Sippl W; Schüle R; Jung M
    Eur J Med Chem; 2018 Jan; 144():52-67. PubMed ID: 29247860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
    El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
    Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in
    Tabata Y; Shidoji Y
    Metabolites; 2022 Feb; 12(2):. PubMed ID: 35208214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
    Duan YC; Ma YC; Qin WP; Ding LN; Zheng YC; Zhu YL; Zhai XY; Yang J; Ma CY; Guan YY
    Eur J Med Chem; 2017 Nov; 140():392-402. PubMed ID: 28987602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.